Author

Michal Magid-Slav

GlaxoSmithKline (United States)ORCID 0000-0001-7272-5754Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Approach:statistical model· 1

Frequent Co-Authors

Deepali Jhamb· 1 shared Mark R. Hurle· 1 shared Pankaj AgarwaliD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Deepali Jhamb

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsDrug Discovery TodayPeer-reviewedMar 29, 2019

Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities

Deepali Jhamb, Michal Magid-Slav, Mark R. Hurle, Pankaj Agarwal

This study uses pathway analysis of GWAS loci to identify novel drug targets and repurposing opportunities for 182 diseases, finding that 30% of diseases have significantly more targets in these pathways than expected by chance.

19 citations

GWAS summary statisticsstatistical model

𝕏 PostBluesky